These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17433757)

  • 1. Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor.
    Alvarez S; Germain P; Alvarez R; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
    Int J Biochem Cell Biol; 2007; 39(7-8):1406-15. PubMed ID: 17433757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function.
    Alvarez S; Khanwalkar H; Alvarez R; Erb C; Martínez C; Rodríguez-Barrios F; Germain P; Gronemeyer H; de Lera AR
    ChemMedChem; 2009 Oct; 4(10):1630-40. PubMed ID: 19670208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
    Klaholz BP; Mitschler A; Moras D
    J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
    Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.
    Nadendla E; Teyssier C; Delfosse V; Vivat V; Krishnasamy G; Gronemeyer H; Bourguet W; Germain P
    PLoS One; 2015; 10(5):e0123195. PubMed ID: 25933005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
    Lund BW; Piu F; Gauthier NK; Eeg A; Currier E; Sherbukhin V; Brann MR; Hacksell U; Olsson R
    J Med Chem; 2005 Dec; 48(24):7517-9. PubMed ID: 16302793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
    Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists.
    Germain P; Gaudon C; Pogenberg V; Sanglier S; Van Dorsselaer A; Royer CA; Lazar MA; Bourguet W; Gronemeyer H
    Chem Biol; 2009 May; 16(5):479-89. PubMed ID: 19477412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands.
    Lund BW; Knapp AE; Piu F; Gauthier NK; Begtrup M; Hacksell U; Olsson R
    J Med Chem; 2009 Mar; 52(6):1540-5. PubMed ID: 19239230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of RAR-selective ligands revealed by RARbeta crystal stucture.
    Germain P; Kammerer S; Pérez E; Peluso-Iltis C; Tortolani D; Zusi FC; Starrett J; Lapointe P; Daris JP; Marinier A; de Lera AR; Rochel N; Gronemeyer H
    EMBO Rep; 2004 Sep; 5(9):877-82. PubMed ID: 15319780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
    Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
    Chen H; Zhang H; Lee J; Liang X; Wu X; Zhu T; Lo PK; Zhang X; Sukumar S
    Cancer Res; 2007 Sep; 67(17):8007-13. PubMed ID: 17804711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice.
    Austenaa LM; Carlsen H; Hollung K; Blomhoff HK; Blomhoff R
    J Nutr Biochem; 2009 Sep; 20(9):726-34. PubMed ID: 18926686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10.
    Zhao X; Graves C; Ames SJ; Fisher DE; Spanjaard RA
    Cancer Res; 2009 Jun; 69(12):5218-25. PubMed ID: 19470764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand recognition by RAR and RXR receptors: binding and selectivity.
    Sussman F; de Lera AR
    J Med Chem; 2005 Oct; 48(20):6212-9. PubMed ID: 16190748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
    Su D; Gudas LJ
    Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
    J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.